{"transactions":[{"id":2231020,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T22:16:14.000Z","date":"2022-06-13","kind":"exercise","acquired":false,"shares":66796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vested and became exercisable on February 14, 2021, and the remainder of the shares underlying the option vest at a rate of 1/36th per month thereafter."}],"balance_after":51954,"derivative":{"exercise_price":1.48,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":66796},"source":{"system":"sec-edgar","filing":"0001562180-22-005121","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218022005121/primarydocument.xml","form_type":"4"}},{"id":2231019,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:16:14.000Z","date":"2022-06-13","kind":"exercise","acquired":true,"shares":66796,"price":1.48,"value":98858.08,"ownership":{"direct":true},"balance_after":497396,"source":{"system":"sec-edgar","filing":"0001562180-22-005121","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218022005121/primarydocument.xml","form_type":"4"}},{"id":2231018,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:16:14.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":1183,"price":4.284,"value":5067.972,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of common stock of Sana Biotechnology, Inc. (the \"Issuer\") pursuant to the Sana Biotechnology, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of November 17, 2021 through May 13, 2022. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 13, 2022."}],"balance_after":430600,"source":{"system":"sec-edgar","filing":"0001562180-22-005121","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218022005121/primarydocument.xml","form_type":"4"}},{"id":2343422,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-03-08T14:04:12.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 3, 2023 and in 36 equal monthly installments thereafter."}],"balance_after":225000,"derivative":{"exercise_price":5.7,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001562180-22-002426","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218022002426/primarydocument.xml","form_type":"4"}},{"id":2377113,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-02-23T22:01:50.000Z","date":"2022-02-18","kind":"sale","acquired":false,"shares":333,"price":6.28,"value":2091.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021."}],"balance_after":429417,"source":{"system":"sec-edgar","filing":"0001562180-22-001784","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218022001784/primarydocument.xml","form_type":"4"}},{"id":2377112,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-02-23T22:01:50.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":1000,"price":18.2325,"value":18232.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of common stock of Sana Biotechnology, Inc. (the \"Issuer\") pursuant to the Sana Biotechnology, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of February 3, 2021 through November 15, 2021. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2021."}],"balance_after":429750,"source":{"system":"sec-edgar","filing":"0001562180-22-001784","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218022001784/primarydocument.xml","form_type":"4"}},{"id":2868383,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-02-10T23:40:03.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":7812,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7812},"source":{"system":"sec-edgar","filing":"0000899243-21-005728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000089924321005728/doc4.xml","form_type":"4"}},{"id":2868382,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2021-02-10T23:40:03.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0000899243-21-005728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000089924321005728/doc4.xml","form_type":"4"}},{"id":2868381,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-10T23:40:03.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":7812,"ownership":{"direct":false,"nature":"Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."}],"balance_after":7812,"source":{"system":"sec-edgar","filing":"0000899243-21-005728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000089924321005728/doc4.xml","form_type":"4"}},{"id":2868380,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":126127,"kind":"person","name":"MacDonald James J.","position":1,"cik":"0001830054","reported_name":"MacDonald James J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-10T23:40:03.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":93750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."}],"balance_after":428750,"source":{"system":"sec-edgar","filing":"0000899243-21-005728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000089924321005728/doc4.xml","form_type":"4"}}]}